findmyKOL
Clinical trialNCT05467800Active, not recruitingPhase 2Interventional

Study of Canakinumab in Patients With Myelofibrosis

SponsorJohn MascarenhasEnrollment14ET-MFPV-MFPost-essential Thrombocythemia MyelofibrosisPost-polycythemia Vera Related MyelofibrosisPrimary Myelofibrosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute

    Los Angeles, California, United States

  • Moffitt Cancer Center

    Tampa, Florida, United States

  • the University of Kansas Cancer Center-Westwood

    Westwood, Kansas, United States

  • Ruttenberg Treatment Center

    New York, New York, United States

  • Atrium Health Levine Cancer Institute

    Charlotte, North Carolina, United States

  • Wake Forest Baptist Health Comprehensive Cancer Center

    Winston-Salem, North Carolina, United States

  • Cleveland Clinic Foundation

    Cleveland, Ohio, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Aug 2022
Primary completion
1 Oct 2026
Completion
1 Jul 2027
Last update posted
7 May 2026
Registered enrollment
14
Registry id
NCT05467800
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.